NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging

(2021) Reza Rahmanzadeh et al.   BRAIN

Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis

(2020) Ali Manouchehrinia et al.   NEUROLOGY

Identifying Progression in Multiple Sclerosis: New Perspectives

(2020) Massimo Filippi et al.   ANNALS OF NEUROLOGY

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

(2020) Stefan Bittner et al.   EBioMedicine

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

(2019) J. William L. Brown et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes

(2019) Gloria Dalla Costa et al.   NEUROLOGY

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies

(2019) Sarah-Jane Martin et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke

(2019) Timo Uphaus et al.   STROKE

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

(2019) Ester Cantó et al.   JAMA Neurology

A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes

(2019) Karen K. Chung et al.   ANNALS OF NEUROLOGY

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

(2018) Ludwig Kappos et al.   LANCET

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

(2018) Nelly Siller et al.   Multiple Sclerosis Journal

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

(2018) Nelly Siller et al.   Multiple Sclerosis Journal

Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

(2018) Finn Sellebjerg et al.   Multiple Sclerosis Journal

Neurofilaments and 10-year follow-up in multiple sclerosis

(2018) Alok Bhan et al.   Multiple Sclerosis Journal

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis

(2018) Tanuja Chitnis et al.   Annals of Clinical and Translational Neurology

Clinical outcome measures for progressive MS trials

(2017) Daniel Ontaneda et al.   Multiple Sclerosis Journal

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

(2017) Lenka Novakova et al.   NEUROLOGY

Clinical outcome measures for progressive MS trials

(2017) Daniel Ontaneda et al.   Multiple Sclerosis Journal

Long-term evolution of multiple sclerosis disability in the treatment era

(2016) et al.   ANNALS OF NEUROLOGY

Defining secondary progressive multiple sclerosis

(2016) Johannes Lorscheider et al.   BRAIN

Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?

(2016) Catherine Larochelle et al.   TRENDS IN NEUROSCIENCES

Defining reliable disability outcomes in multiple sclerosis

(2015) Tomas Kalincik et al.   BRAIN

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis

(2014) Ilana Katz Sand et al.   Multiple Sclerosis Journal

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Competing risks with missing covariates: effect of haplotypematch on hematopoietic cell transplant patients

(2012) Thomas H. Scheike et al.   LIFETIME DATA ANALYSIS

Neurofilament light as a prognostic marker in multiple sclerosis

(2010) Jonatan Salzer et al.   Multiple Sclerosis Journal